Financials
| Half-year Report | Jul. 16, 2025 |
| Trading Statement | May. 21, 2025 |
| Annual Financial Report | Mar. 13, 2025 |
| Annual Financial Report | Mar. 13, 2025 |
| Annual Financial Report | Mar. 13, 2025 |
| 2024 Full Year Results | Mar. 06, 2025 |
| Trading Statement | Nov. 20, 2024 |
Proxies
| Result of AGM | May. 21, 2025 |
| Resolutions passed at Annual General Meeting | May. 21, 2025 |
| Form of Proxy | Mar. 19, 2025 |
| Notice of Annual General Meeting | Mar. 19, 2025 |
| Resolutions passed at Annual General Meeting | May. 22, 2024 |
| Result of AGM | May. 22, 2024 |
| Proposed 2024 Deferred Annual Bonus Plan (DABP) Rules | Mar. 19, 2024 |
Ownership Update
| Director/PDMR Shareholding | Dec. 17, 2025 |
| Director/PDMR Shareholding | Oct. 20, 2025 |
| Holding(s) in Company | Oct. 17, 2025 |
| Holding(s) in Company | Sep. 12, 2025 |
| Holding(s) in Company | Sep. 11, 2025 |
| Director/PDMR Shareholding | Sep. 10, 2025 |
| Holding(s) in Company | Sep. 03, 2025 |
Announcements
| Completion of OrthoLite acquisition | Oct. 30, 2025 |
| Block listing Interim Review | Oct. 06, 2025 |
| Director Declaration | Sep. 16, 2025 |
| Total Voting Rights | Jul. 31, 2025 |
| Further Information re Acquisition of OrthoLite | Jul. 29, 2025 |
| Results of Capital Raise | Jul. 17, 2025 |
| Acquisition - Retail Offer Launch (Replacement) | Jul. 16, 2025 |
Prospectuses
| $250m US private placement | Feb. 20, 2023 |